Quipt Home Medical Corp. (QIPT)
Mar 16, 2026 - QIPT was delisted
3.650
0.00 (0.00%)
Inactive · Last trade price on Mar 13, 2026
Quipt Home Medical Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| 229.68 | 245.92 | 211.68 | 139.86 | 102.35 | 72.64 | |
Revenue Growth | -7.05% | 16.18% | 51.35% | 36.65% | 40.90% | 18.82% |
Cost of Revenue | 65.44 | 68.93 | 57.9 | 33.21 | 28.17 | 19.93 |
Gross Profit | 164.24 | 176.99 | 153.78 | 106.65 | 74.18 | 52.71 |
Selling, General & Admin | 122.78 | 122.54 | 103.22 | 65.2 | 44.81 | 38.63 |
Depreciation & Amortization Expenses | 41.41 | 44.58 | 36.1 | 23.04 | 17.79 | 14.54 |
Other Operating Expenses | 10.25 | 8.97 | 11.76 | 13.68 | 13.05 | -0.97 |
Total Operating Expenses | 174.44 | 176.09 | 151.08 | 101.92 | 75.64 | 52.2 |
Operating Income | -4.21 | 1.12 | 2.85 | 4.73 | -1.46 | 0.66 |
Interest Income | 0.66 | 0.79 | 0.37 | - | - | - |
Interest Expense | -5.03 | -7.17 | -5.91 | -2.08 | -1.99 | -1.84 |
Other Non-Operating Income (Expense) | 0.16 | 0.86 | -0.01 | -2.02 | 1.31 | 2.48 |
Total Non-Operating Income (Expense) | -4.21 | -5.53 | -5.55 | -4.1 | -0.69 | 0.64 |
Pretax Income | -10.54 | -6.65 | -2.7 | 2.94 | -9.33 | -3.58 |
Provision for Income Taxes | -0.27 | 0.11 | 0.09 | -1.9 | -3.16 | 0.13 |
Net Income | -10.26 | -6.76 | -2.78 | 4.84 | -6.17 | -3.7 |
Earnings From Discontinued Operations | - | - | - | - | - | -0.87 |
Net Income to Common | -10.26 | -6.76 | -2.78 | 4.84 | -6.17 | -4.57 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 43 | 43 | 39 | 34 | 30 | 23 |
Shares Outstanding (Diluted) | 43 | 43 | 39 | 36 | 30 | 23 |
Shares Change | 2.24% | 10.09% | 6.35% | 19.27% | 33.96% | -72.82% |
EPS (Basic) | -0.24 | -0.16 | -0.07 | 0.14 | -0.20 | -0.20 |
EPS (Diluted) | -0.24 | -0.16 | -0.07 | 0.13 | -0.20 | -0.20 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Free Cash Flow | 24.12 | 25.07 | 30.13 | 17.18 | 12.72 | 13.94 |
Free Cash Flow Growth | -19.28% | -16.79% | 75.34% | 35.14% | -8.81% | 98.48% |
Free Cash Flow Per Share | 0.56 | 0.59 | 0.78 | 0.47 | 0.42 | 0.61 |
Gross Margin | 71.51% | 71.97% | 72.65% | 76.25% | 72.48% | 72.56% |
Operating Margin | -1.83% | 0.45% | 1.35% | 3.38% | -1.43% | 0.91% |
Profit Margin | -4.47% | -2.75% | -1.32% | 3.46% | -6.03% | -5.10% |
FCF Margin | 10.50% | 10.19% | 14.23% | 12.29% | 12.42% | 19.19% |
EBITDA | 37.2 | 45.7 | 38.95 | 27.77 | 16.33 | 15.2 |
EBITDA Margin | 16.20% | 18.58% | 18.40% | 19.86% | 15.95% | 20.93% |
EBIT | -4.21 | 1.12 | 2.85 | 4.73 | -1.46 | 0.66 |
EBIT Margin | -1.83% | 0.45% | 1.35% | 3.38% | -1.43% | 0.91% |
Effective Tax Rate | 2.60% | -1.64% | -3.15% | -64.87% | 33.82% | -3.58% |